Guillain Barre Syndrome is an AIDP (acute inflammatory demyelization polyneuropathy), autoimmune disorder which affects nervous system. It is triggered by various infectious processes like flu, for example. In acute infections, one’s immune system is mistargeting invading agents and attacks the nerve tissue.
This causes a damage of myelin, fat protective layer of the nerve, after which nerves become blocked. This leads to massive muscle paralysis.
Guillain Barre Syndrome is very rare and it occurs on one or two person per hundred of thousands individuals.
Doctors are recognizing GBS syndrome by testing the cerebrospinal fluids and by using electro diagnostics.
In most of the patients recovery begins four weeks after the peak of disorder. Nearly 80% of patients are fully recovered after a couple of months up to 1 year, however certain percentage recover only partly with severe disabilities. Death rate for the disorder is 2-3%.
The syndrome is named after Georges Guillain and Jean Alexandre Barre. They diagnosed this disorder in 1917 in two soldiers. However disorder was first described by Jean Laundry a French physician back in 1859.